References
- Park S., Merlat A., Guesnu M., Picard F., Viguie F., Vassilieff D. Pure red cell aplasia associated with myelodysplasia syndromes. Leukemia 2000; 1709–1710
- Garcia-Suarez J., Pascual T., Munoz M. A., Herrero B., Pardo A. Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. Am. J. Hematol. 1988; 58: 319–325
- Charles R. J., Sabo K. M., Kidd P. G., Abkowitz J. L. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996; 11: 4831–4838
- Means R. T., Dessypris E. N., Krantz S. B. 'Treatment of refractory pure red cell aplasia with cyclosporin A: disappearance of IgG inhibitor associated with clinical response. Br. J. Haematol. 1991; 78: 114–119
- Jonasova A., Neuwirtova R., Cermak J., Vozobulova V., Mocikova K., Siskova M., Hochova I. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br. J. Haematol. 1998; 100: 304–309
- Begley C. G., Basser R., Mansfield R., Thomson B., Parker W., Layton J., To B., Cebon J., Sheridan W. P., Fox R. M., Green M. D. Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans. Blood 1997; 90: 3378–3389
- Casadevall N., Dupuy E., Molho-Sabatier P., Tobelem G., Varet B., Mayeux P. Brief report: autoantibodies against erythropoietin in a patient with pure red-cell aplasia. New Engl. J. Med. 1996; 10: 630–633
- Abkhowitz J. L., Kadin M. E., Powell J. S., Adamson J. W. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br. J. Haematol. 1986; 63: 59–62
- Cook M. K. Red cell hypoplasia associated with myeloproliferative and myelodysplastic syndrome. J. Clin. Pathol. 1989; 42: 890–891
- Motoji T., Teramura M., Takahashi M., et al. Successful treatment of refractory anemia with high-dose methylprednisolone. Am. J. Hematol. 1990; 37: 25–33
- Editorial. Cyclosporin in autoimmune disease. Lancet 1985; I: 909–911